Early-career Members Network
The Early-career Members Network of the Metabolomics Society
Travel Grant 2018: Award Scheme
The Early-career Members Network of the Metabolomics Society Travel Grant aims at providing support to Early-Career scientists* to attend and actively participate in national and international events related to the metabolomics field that will promote their professional development.
Eligible applicants must be:
- A member of the Metabolomics Society; and
- Within 5 years of obtaining their highest degree.
Winners will be notified by e-mail by April 1st 2018 and announced on the Metabolomics Society website and in the MetaboNews. Travel awards will be valid through 12 months from the date of announcement. Selected abstract and conference reports will be published in the MetaboNews and/or on the Metabolomics Society website.
Click here for FAQs.
*All members of the Metabolomics Society that are graduate students (Masters or PhD) or within 5-years post PhD while being in a training position (e.g. post-doc) are considered Early-Career scientists. In certain cases where someone if beyond the 5-year post-PhD limit, exceptions can be made if time off was taken for personal reasons (e.g. family, career break). Any persons with 5-years full-time work experience (or equivalent) after obtaining their PhD shall not be considered an Early Career scientist.
The network aims to provide a forum for metabolomics researchers at the start of their professional career and serve the early-career members of the Metabolomics Society. Aspirations include, but are not limited to: strengthen communication and collaboration, encourage opportunities and invention, support developmental learning and enjoy professional growth.
Establish a real sense of community and engagement between early-career researchers globally through leading initiative and enthused apparition.
Any early-career scientists, throughout the world, who are either currently conducting higher degrees (MSc, PhD etc.) or are within 5 years of completing such endeavours, and actively engaged in the field of metabolomics.
Some of the EMN programs:
EMN Webinar series: The EMN committee organizes monthly (live streamed) webinar sessions on metabolomics related topics, covering (i) back to basics, (ii) informal training, (iii) debating sessions and (iv) ad hoc session categories. Please find some of the EMN webinar series sessions online archived here.
EMN Travel Bursary Program: this outreach program is to provide support to early-career member scientists (including graduate students and post-docs) to attend national and international events, including the annual conference of the Metabolomics Society, related to the metabolomics field. This bursary program is aimed at the growing population of early-career scientists and encourages active participation in events that will promote the Metabolomics Society to a wider audience. Early-career scientists are invited to apply for a bursary ($500) towards the cost of travel and conference/event fees to national or international meetings related to metabolomics. The first competition will be held in late 2017. Watch this space for more information.
EMN Facebook page: The EMN Committee Facebook account is a flexible social platform to engage and communicate within the larger community of early career scientists (members and non-members of the Metabolomics Society). At this social platform you will find out who the EMN Committee members are, the EMN activities and programs, learn about the resources that the Metabolomics Society offers, network with early career scientists around the world, and learn about the new and exciting metabolomics research, tools and Society Forum. Please find and like the EMN Facebook page here.
The EMN is dedicated to, and run by early-career scientists who are members of the Metabolomics Society and are from either academia, government or industry.
- Chair: Charmion Cruickshank-Quinn, University of Colorado, Anschutz Medical Campus (USA)
- Tim Causon, University of Natural Resources and Life Sciences (BOKU Vienna) (Austria)
- Romanas Chaleckis, Kyoto University, Graduate school of Biostudies (Japan)
- Dara Daygon, University of Queensland, St Lucia (Australia)
- Johannes Francois Fahrmann, University of Texas, MD Anderson (USA)
- Ricardo Heredia, University College London (UK)
- Christina Jones, NIST (USA)
- Julia Kuligowski, IIS La Fe (Spain)
- Zhanlong Mei, University of Copenhagen (Denmark)
- Isabel Orf, Bactevo Pharmaceutical Company (UK)
- Umaporn Uawisetwathana, National Center for Genetic Engineering (Thailand)
- Candice Ulmer, University of Florida (USA)
- Stacey Reinke, Murdoch University (Australia)